PhytoNexus

PhytoNexus

Department of Pharmacognosy · Herb-Drug Interaction Intelligence Platform · generated 27 Jul 2026 01:09 IST
Open science

Search the live literature, not a snapshot

Six public APIs, no keys and no paywall. Queries are scoped to title and abstract rather than full text, because a full-text hit on Curcuma in a reference list is not evidence of anything. Everything retrieved is then passed through an interaction-vocabulary gate: a paper is admitted only if it actually describes an interaction, not merely because it names a plant and a drug in the same abstract. What survives is ranked against an eight-level evidence hierarchy, so a randomised trial outranks a review that cites it.

Sources to query
Reset
Terms the engine will send
antiparkinsonian drugs levodopa preparations levodopa preparation carbidopa levodopa Levodopa and antiparkinsonian drugs
Mechanism being tested

Levodopa and antiparkinsonian drugs PK-absorption + PD-antagonistic

Mucuna species contain L-DOPA itself, so co-administration is unblinded dose escalation. High-protein and high-pyridoxine botanical products reduce levodopa absorption and central availability, and dopamine-antagonist constituents oppose its effect.

Expected clinically: Dyskinesia and hypotension from additive L-DOPA; unpredictable off periods and motor fluctuation from reduced absorption.

Retrieved records

Records are ranked by the local hierarchy, not by relevance as the upstream service judges it. Nothing here is written to the knowledge base until a signed-in curator attaches it to a monograph, which keeps retrieval and curation as separate steps.